TickerFactsScreenerDevelopers

RELMADA THERAPEUTICS, INC. (RLMD) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2012: -$1.58M2013: -$2.24M2015: -$16.23M2016: -$13.14M2017: -$6.47M2018: -$6.00M2019: -$12.09M2020: -$27.81M2021: -$91.87M2022: -$103.80M2023: -$51.66M2024: -$51.76M2025: -$45.79M-$45.79M
2012Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$45.79M+11.5%
2024-$51.76M-0.2%
2023-$51.66M+50.2%
2022-$103.80M-13.0%
2021-$91.87M-230.4%
2020-$27.81M-130.0%
2019-$12.09M-101.5%
2018-$6.00M+7.2%
2017-$6.47M+50.8%
2016-$13.14M+19.0%
2015-$16.23M—
2013-$2.24M-41.3%
2012-$1.58M—